Skip to main content
Clinical Trials/JPRN-UMIN000008858
JPRN-UMIN000008858
Completed
Phase 2

Clinical study to investigate the therapeutic effect of 1-kestose on atopic dermatitis - Effect of 1-kestose on atopic dermatitis

Tokai University School of Medicine0 sites120 target enrollmentSeptember 5, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Atopic dermatitis
Sponsor
Tokai University School of Medicine
Enrollment
120
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 5, 2012
End Date
April 30, 2014
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Users of external corticosteroids that are classified as "very strong" or "stronger" 2\. Patients who regularly use probiotics/prebiotics other than 1\-kestose for therapeutic purposes 3\. Patients who regularly use antibiotics 4\. Patients who are judged as ineligible by doctor in charge

Outcomes

Primary Outcomes

Not specified

Similar Trials